HC Wainwright & Co. Reiterates Buy on Genelux, Maintains $32 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar reiterated a Buy rating on Genelux (NASDAQ:GNLX) with a maintained price target of $32.
May 13, 2024 | 5:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genelux maintains a Buy rating from HC Wainwright & Co. with a price target of $32, indicating strong confidence in the company's future performance.
The reiteration of a Buy rating and a maintained price target of $32 by a reputable analyst firm like HC Wainwright & Co. suggests a strong bullish outlook for Genelux. This endorsement is likely to instill confidence among investors, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90